VIM and adenomyosis: Therefore, STAT3, VIM, VEGFA and HSP90B1 that were also annotated in interleukin-4 and interleukin-13 signalling in the present GSEA need to be validated to verify potential downregulation of this pathway in women with adenomyosis.